β 3Gn-T2 Antibodies

Santa Cruz Biotechnology features a diverse variety of β3Gn-T2 monoclonal antibodies for research in glycosylation and its implications in various biological processes. β3Gn-T2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β3Gn-T2, or beta-1,3-N-acetylglucosaminyltransferase 2, plays a critical role in the biosynthesis of complex carbohydrates, influencing cell signaling and adhesion. β3Gn-T2 is essential for the proper functioning of various cellular processes, including development and immune response. Understanding β3Gn-T2 in glycosylation pathways can provide insights into disease mechanisms and potential therapeutic targets. Research focused on β3Gn-T2 continues to reveal new aspects of cellular regulation and development. Investigating β3Gn-T2 functions helps advance our understanding of glycobiology and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies for β3Gn-T2 research support scientists worldwide in advancing glycobiology knowledge and developing new therapeutic strategies.